Operating Partner
Current
Aug 2023 - Present
AeroLeads people directory · profile
Daniel Chao Email & Phone Number
Biotech and medtech entrepreneur, exec and investor
at
Palo Santo
1 work email found
@rubryc.com
4 phones found area 512, 415, 650, and 617
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 86%
Current company
Role
Biotech and medtech entrepreneur, exec and investor
Location
San Francisco Bay Area, United States
Who is Daniel Chao? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Daniel Chao is listed as Biotech and medtech entrepreneur, exec and investor at Palo Santo, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at rubryc.com, phone signal with area code 512, 415, 650, 617, and a matched LinkedIn profile for Daniel Chao.
Daniel Chao previously worked as Operating Partner at Palo Santo and Senior Advisor to the CEO at Ibio, Inc.. Daniel Chao holds Ms, Neuroscience from Stanford University School Of Medicine.
Company email context
Email format at Palo Santo
This section adds company-level context without repeating Daniel Chao's masked contact details.
{first}.{last}@rubryc.com
86% confidence
AeroLeads found 1 current-domain work email signal for Daniel Chao. Compare company email patterns before reaching out.
Profile bio
About Daniel Chao
Daniel Chao is a Biotech and medtech entrepreneur, exec and investor at Palo Santo. Colleagues describe him as "Brilliant med student, collegial and professional."
Current workplace
Daniel Chao's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles
Daniel Chao work experience
A career timeline built from the work history available for this profile.
Senior Advisor To The Ceo
I led the business integration of Rubryc into iBio and then supported company leadership in deal making and fund raising strategy
Sep 2021 - Nov 2023
Chief Business Officer
Rubryc integrates biochemistry and computation to discover therapeutic antibodies with unprecedented speed and performance. As CBO, I lead inbound and outbound deal assessment, due diligence, negotiation and execution. I also lead and support M/A and fund raising discussions and contribute to product and platform strategy. In Sept 2022, we successfully sold the Rubryc discovery platform to iBio (NYSE: IBIO)
Jul 2021 - Sep 2022
Chief Executive Officer And Board Of Directors
I took the helm of Herophilus in its fourth year of operation, inheriting a company with 65 employees and bluechip backers including Pfizer Ventures and CRV. Against the head winds of the pandemic, we boldly marched forward and made 2020 our most productive year. Together we signed our first deal with Genentech and generated our first "hit." In 2023, Genentech would later acquire the Herophilus platform
Mar 2020 - May 2021
Board Of Directors
Apr 2019 - Nov 2020
Co-Founder, Ceo, Board Of Directors
Co-founded and led the company as CEO from 2013 to 2019. Raised $30M+ in capital from top tier VCs including Andreessen Horowitz, TPG, Lux Capital, Xfund and JAZZ Venture Partners. Grew the team to 35 employees while pioneering the global market of consumer neurostimulation with our flagship product, Halo Sport. In 2020, Halo was acquired by Flow Neuroscience
Oct 2013 - Apr 2019
Board Of Advisors, Ann Romney Center For Neurologic Diseases
Advised department leadership, Dennis Selkoe and Howard Weiner, on scientific strategy and direction. Supported efforts in fund raising with other Board members. Stepped down in 2020 due to conflict of interest with me taking the CEO role at System1 Bioscience
Nov 2018 - Nov 2020
Business Development And Product Management
NASDAQ: NPCE. Early employee reporting directly to the CEO, helped raise $250M in capital and grow the team to 150+ employees. I was responsible for all business development activities including deals signed with multiple neurosurgical tools providers. Early in my tenure, I started leading development programs and soon covered all patient and neurologist facing products (e.g., patient remote monitor, patient controller, and physician programmer)
Apr 2006 - Sep 2013
Senior Associate
Jan 2004 - Mar 2006
Analyst
Jan 2002 - May 2003
3 education records
Daniel Chao education
Ms, Neuroscience
Stanford University School Of Medicine
Md
Stanford University School Of Medicine
Ba, Biochemistry
University Of California, Berkeley
FAQ
Frequently asked questions about Daniel Chao
Quick answers generated from the profile data available on this page.
What company does Daniel Chao work for?
Daniel Chao works for Palo Santo.
What is Daniel Chao's role at Palo Santo?
Daniel Chao is listed as Biotech and medtech entrepreneur, exec and investor at Palo Santo.
What is Daniel Chao's email address?
AeroLeads has found 1 work email signal at @rubryc.com for Daniel Chao at Palo Santo.
What is Daniel Chao's phone number?
AeroLeads has found 4 phone signal(s) with area code 512, 415, 650, 617 for Daniel Chao at Palo Santo.
Where is Daniel Chao based?
Daniel Chao is based in San Francisco Bay Area, United States while working with Palo Santo.
What companies has Daniel Chao worked for?
Daniel Chao has worked for Palo Santo, Ibio, Inc., Rubryc Therapeutics, Herophilus, and Halo Neuroscience.
How can I contact Daniel Chao?
You can use AeroLeads to view verified contact signals for Daniel Chao at Palo Santo, including work email, phone, and LinkedIn data when available.
What schools did Daniel Chao attend?
Daniel Chao holds Ms, Neuroscience from Stanford University School Of Medicine.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial